Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
Cremer, PC; Abbate, A; Hudock, K; McWilliams, C; Mehta, J; Chang, SY; Sheng, CC; Van Tassell, B; Bonaventura, A; Vecchié, A; et al.
The Lancet. Rheumatology.
2021;
3:e410-e418.
Whole-Lung Lavage.
Towe, C; Trapnell, B.
Diagnostic and Interventional Bronchoscopy in Children.
2021.
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
Trapnell, BC; Inoue, Y; Bonella, F; Morgan, C; Jouneau, S; Bendstrup, E; Campo, I; Papiris, SA; Yamaguchi, E; Cetinkaya, E; et al.
New England Journal of Medicine.
2020;
383:1635-1644.
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
De Luca, G; Cavalli, G; Campochiaro, C; Della-Torre, E; Angelillo, P; Tomelleri, A; Boffini, N; Tentori, S; Mette, F; Farina, N; et al.
The Lancet. Rheumatology.
2020;
2:e465-e473.
Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia.
Hudock, KM; Collins, MS; Imbrogno, M; Snowball, J; Kramer, EL; Brewington, JJ; Gollomp, K; McCarthy, C; Ostmann, AJ; Kopras, EJ; et al.
American Journal of Physiology - Lung Cellular and Molecular Physiology.
2020;
319:L137-L147.
CO0001 MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPER-INFLAMMATION.
De Luca, G; Cavalli, G; Campochiaro, C; Della Torre, E; Angelillo, P; Tomelleri, A; Boffini, N; Tentori, S; Mette, F; Rovere-Querini, P; et al.
Annals of the Rheumatic Diseases.
2020;
79:213-213.
Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis.
Hetzel, M; Lopez-Rodriguez, E; Mucci, A; Ha Nguyen, AH; Suzuki, T; Shima, K; Buchegger, T; Dettmer, S; Rodt, T; Bankstahl, JP; et al.
Haematologica.
2020;
105:1147-1157.
A novel approach to conducting clinical trials in the community setting: utilizing patient-driven platforms and social media to drive web-based patient recruitment.
Applequist, J; Burroughs, C; Jr, RA; Merkel, PA; Rothenberg, ME; Trapnell, B; Desnick, RJ; Sahin, M; Krischer, JP.
BMC Medical Research Methodology.
2020;
20.
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis.
Suzuki, T; McCarthy, C; Carey, BC; Borchers, M; Beck, D; Wikenheiser-Brokamp, KA; Black, D; Chalk, C; Trapnell, BC.
American Journal of Respiratory Cell and Molecular Biology.
2020;
62:87-94.
Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy.
Trapnell, BC; Chen, S; Khurmi, R; Bodhani, A; Kapoor, M; Haupt, M.
Chronic Respiratory Disease.
2020;
17.